In T2DM, insulin signaling is disrupted in skeletal muscle, with increased serine phosphorylation of insulin receptor substrate 1 (IRS1), decreased AKT phosphorylation, and reduced translocation of the glucose transporter GLUT4 to the sarcolemmal membrane, thus impairing glucose uptake [3]. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.